Stock A140610 ENSOL BIOSCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Ensol Biosciences Inc.

Equities

A140610

KR7140610007

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 14/07/2024 BST 		5-day change 1st Jan Change
6,090 KRW -8.97% Intraday chart for Ensol Biosciences Inc. -12.50% -2.09%
07-10 Spine BioPharma, Inc. Announces Agreement with Ensol BioSciences, Inc. to Expand Indications for SB-01 For Injection CI
2023 Ensol Biosciences Inc. announced that it has received KRW 4.99999995 billion in funding from Humedix Co., Ltd. CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Spine BioPharma, Inc. Announces Agreement with Ensol BioSciences, Inc. to Expand Indications for SB-01 For Injection
CI
Ensol Biosciences Inc. announced that it has received KRW 4.99999995 billion in funding from Humedix Co., Ltd.
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 4.99999995 billion in funding from Humedix Co., Ltd.
CI
Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment Day
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 5 billion in funding from Gluon Bond Investment Day
CI
Ensol Biosciences Inc. announced that it has received KRW 2 billion in funding
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 2 billion in funding
CI
Ensol Biosciences Inc. announced that it has received KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.
CI
Ensol Biosciences Inc. announced that it has received KRW 6.9999856 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 6.9999856 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm
CI
Ensol Biosciences Inc. announced that it has received KRW 10.999926 billion in funding
CI
Ensol Biosciences Inc. announced that it expects to receive KRW 10.999926 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A140610 Stock
  4. News Ensol Biosciences Inc.